ABI Researcher Wins Early Career Research Excellence Award

23 May 2017
pull-out-quote
tim-angeli-ecrea
Dr Angeli with his award, flanked by his colleagues from the Gastrointestinal Research Group

The Auckland Bioengineering Institute (ABI) would like to extend its heartfelt congratulations to Dr Timothy Angeli for receiving the Early Career Research Excellence Award recently. The award recognises and promotes excellence and research leadership potential among emerging researchers at the University and is worth up to $25,000.

Dr Angeli is currently a Research Fellow with the Gastrointestinal (GI) Research Group and his work focuses on GI electrophysiology. His aim is to develop novel diagnostics and therapeutics for debilitating GI disorders by integrating findings across the fields of engineering, physiology and medicine.

An up-and-coming researcher, Dr Angeli is currently supported by the prestigious Edith C. Coan Postdoctoral Fellowship from the Auckland Medical Research Foundation. Dr Angeli also holds the position of Associate Investigator at the MedTech Centre of Research Excellence. In addition to that, he is a Senior Biomedical Engineer at FlexiMap Limited; Fleximap is a commercial spin-out company whose aim is to advance physiological solutions for patients with GI motility disorders through research, diagnosis and management of these conditions.

Dr Angeli’s achievements include publications in the field-leading journal, "Gastroenterology,” and numerous awards, including the 2016 Young Investigator Award from the American Gastroenterological Association and the 2013 Distinguished Young Investigator Award from the American Neurogastroenterology and Motility Society. The GI Research Group also received the University of Auckland Research Excellence Award last year.

Dr Angeli says that he feels immensely honoured to receive this award. “This award will be extremely valuable to my academic research career, but most importantly, it will enable research that could help patients suffering from severe, debilitating GI disorders,” he remarks.

Distinguished Professor Peter Hunter, Director of the ABI and Dr Angeli’s academic head, notes that “remarkably, Dr Angeli is winning awards across three areas: basic science, clinical applications and commercialisation of research.”

The ABI extends its best wishes to Dr Angeli, and looks forward to his further contributions in the field of GI research.